Skip to content
Use caution Medical device recall · FDA · Published August 13, 2025

Beta Bionics iLet Ace Pump Kit Software Recalls: Unauthorized Access Risk

Beta Bionics recalls iLet Ace Pump Kit software versions 1.3.7, 1.4.2, and 1.4.3 due to potential unauthorized access causing severe hypoglycemia. Affected users should check their software version.

🇺🇸 FDA recall #Z-1809-2026Medical deviceBeta Bionics ›
Take action

Contact the company

Recalling firmBeta Bionics, Inc.11 Hughes · Irvine, CA 92618-1902
✎ GovInfoNow plain-language explainer

Beta Bionics is recalling iLet Ace Pump Kit software versions 1.3.7, 1.4.2, and 1.4.3 because a security flaw allows unauthorized access to the device while in Limited Access Mode, which could lead to severe hypoglycemia. This risk affects users who have the specific software versions listed. Read more at govinfonow.com/recall/51615-beta-bionics-ilet-ace-pump-kit-software-recalls-unauthorized-access.

Source Summary by GovInfoNow · govinfonow.com/recall/51615-beta-bionics-ilet-ace-pump-kit-software-recalls-unauthorized-access · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1809-2026

Cite this page

“Beta Bionics iLet Ace Pump Kit Software Recalls: Unauthorized Access Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/51615-beta-bionics-ilet-ace-pump-kit-software-recalls-unauthorized-access. Based on FDA recall #Z-1809-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1809-2026%22&limit=1).

The FDA announced on Aug. 13, 2025, that Beta Bionics, Inc. is recalling the iLet Ace Pump Kit (REF: BB1001) due to a software flaw allowing unauthorized access. This vulnerability could lead to severe hypoglycemia if users bypass security screens. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Beta Bionics
  • Product: iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software
  • Affected Units: ILet Ace Pumps containing software version BOM000036 Rev C (version 1.4.2) or older
  • Quantity: 15 units

The hazard

According to the FDA, versions 1.3.7, 1.4.2, and 1.4.3 of the iLet graphical user interface display active icons on the Lock Screen and Limited Access Passcode Screen status bar. Pressing these icons allows users to bypass security screens, enabling unauthorized access while the device is in Limited Access Mode. The agency states this could result in severe hypoglycemia due to unauthorized meal announcements or stopped insulin delivery.

Context

GovInfoNow's records show Beta Bionics, Inc. has two other recalls on record since Sept. 23, 2025. On March 12, 2026, the company recalled iLet Bionic Pancreas Software 1.4.2/1.4.3 due to delayed glucose readings risk. Other recent recalls of similar products include Medtronic MiniMed 780G Insulin Pump Recall: Software Error Causes Insulin Stoppage (May 27, 2026), Medtronic MiniMed 780G Insulin Pump Recall: Risk of Incorrect Insulin Delivery (July 13, 2026), and Medtronic MiniMed 640G Insulin Pump Recall: Risk of Incorrect Insulin Delivery (July 13, 2026).

How to tell if you have this one

Check your iLet Ace Pump Kit software version. Affected units have software version BOM000036 Rev C (1.4.2) or older. The recall covers iLet Ace Pumps with these specific software versions.

  • Brand
    Beta Bionics
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Software Version

    Look for the software version number on your iLet Ace Pump Kit. Affected units have version 1.3.7, 1.4.2, or 1.4.3.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 39 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: nationwideMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, ID, IL, IN, LA, MA, MD, ME, MI, ME, MI, MN, MO, MT, NC, NE, NH, NJ, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WI, WY AND WASHINGTON DC.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 8 months after the firm started it.

1. Firm started the recall: Aug 13, 202512. FDA classified it Class II: Apr 10, 202623. Published in FDA’s Enforcement Report: Apr 22, 2026320252026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Do I need to do anything if I have the correct software version?

No action is needed if your software version is newer than 1.4.3.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1809-2026 (August 13, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1809-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA